Cite
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
MLA
Lin, Chuan-Pin, et al. “Concordance of SVR12, SVR24 and SVR Durability in Taiwanese Chronic Hepatitis C Patients with Direct-Acting Antivirals.” PLoS ONE, vol. 16, no. 2, Feb. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1371/journal.pone.0245479.
APA
Lin, C.-P., Liang, P.-C., Huang, C.-I., Yeh, M.-L., Hsu, P.-Y., Hsu, C.-T., Wei, Y.-J., Liu, T.-W., Hsieh, M.-Y., Hou, N.-J., Jang, T.-Y., Lin, Y.-H., Wang, C.-W., Lin, Z.-Y., Chen, S.-C., Huang, C.-F., Huang, J.-F., Dai, C.-Y., Chuang, W.-L., & Yu, M.-L. (2021). Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals. PLoS ONE, 16(2), 1–9. https://doi.org/10.1371/journal.pone.0245479
Chicago
Lin, Chuan-Pin, Po-Cheng Liang, Ching-I Huang, Ming-Lun Yeh, Po-Yao Hsu, Cheng-Ting Hsu, Yu-Ju Wei, et al. 2021. “Concordance of SVR12, SVR24 and SVR Durability in Taiwanese Chronic Hepatitis C Patients with Direct-Acting Antivirals.” PLoS ONE 16 (2): 1–9. doi:10.1371/journal.pone.0245479.